Diagnostics
We call our Patented Diagnostic PeloFIND-AI
-
Measures a molecular marker of Active wound Infection
-
Uses just a few microliters of wound fluid to measure wound infection status
-
Indicates the level of wound infection within minutes
-
Quantitatively indicates whether infection is improving, staying static, or getting worse from one patient visit to the next
-
The measurement of active wound infection at each patient visit guides the wound physician’s therapeutic management strategy
-
PeloFIND-AI provides NAVIGATIONAL THERAPEUTIC WOUND MANAGEMENT

Open Wound on Shin
- Small amount serous drainage
- Well defined wound edge
- Chronic wound being treated
Concentration of molecular marker of wound infection: 39 μg/mL

Diabetic Foot Ulcer
- Small amount serous drainage
- Surrounding tissue discolored
and excoriated
- Chronic wound being treated
Concentration of molecular marker of wound infection: 78 μg/mL

Pressure Ulcer on Heel
- Copious serous drainage
- Well defined wound edge
- Chronic wound being treated
Concentration of molecular marker of wound infection: 62 μg/mL

CONTROL Acute Wound
3rd Degree Burn
- Small amount serous drainage
- Surrounding tissue pink
Concentration of molecular marker of wound infection: <1 μg/mL

Studies performed to date indicate that the results from PeloFIND-AI group into three ranges as follows:
-
Normal range where there is no active infection in a wound. Found in most Acute wounds on normal healing trajectories.
-
Range of moderately elevated levels of the molecular marker of active infection. Often found in wounds responding to treatment
-
Range of highly elevated levels of the molecular marker of active infection. Found in many newly presenting wounds and wounds not responding to current therapeutic strategy.
PeloFIND-AI is expected to have application in other types of active infection causing stress in the human or animal host, including:
(a) Periodontal Disease
(i) periodontitis
(ii) gingivitis
(b) Chronic Obstructive Pulmonary Disease
(i) emphysema
(ii) chronic bronchitis
(iii) refractory (non-reversible) asthma
(c) Cystic Fibrosis